{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:12:02Z","timestamp":1791079922240,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04115-3","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T08:02:49Z","timestamp":1753344169000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Development and validation of a nomogram-based risk prediction model for non-alcoholic fatty liver disease (NAFLD): a logistic regression analysis in a physical examination population"],"prefix":"10.1186","volume":"25","author":[{"given":"Jing","family":"Lan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Que","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichan","family":"Ban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"issue":"7","key":"4115_CR1","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","volume":"158","author":"TG Cotter","year":"2020","unstructured":"Cotter TG, Rinella MN. Nonalcoholic Fatty Liver Disease 2020: The State of the Disease. Gastroenterology. 2020;158(7):1851\u201364.","journal-title":"Gastroenterology"},{"issue":"3","key":"4115_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray FG. Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4115_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.arcmed.2020.11.010","volume":"52","author":"E Makri","year":"2021","unstructured":"Makri E, Goulas A, Polyzos SA. Epidemiology, pathogenesis, diagnosis and emerging treatment of nonalcoholic fatty liver disease. Arch Med Res. 2021;52(1):25\u201337.","journal-title":"Arch Med Res"},{"issue":"9","key":"4115_CR4","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, Swain MG, Congly SE, Kaplan GG. Shaheen aa.the prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(9):851\u201361.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"4115_CR5","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","volume":"69","author":"C Estes","year":"2018","unstructured":"Estes C, Anstee QM, Arias-Loste MT, Bantel H, Bellentani S, Caballeria J, Colombo M, Craxi A, Crespo J, Day CP, et al. Modeling NAFLD disease burden in china, france, germany, italy, japan, spain, united kingdom, and united States for the period 2016\u20132030. J Hepatol. 2018;69(4):896\u2013904.","journal-title":"J Hepatol"},{"key":"4115_CR6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1146\/annurev-med-042220-020407","volume":"73","author":"Y Saiman","year":"2022","unstructured":"Saiman Y, Duarte-Rojo A, Rinella ME. Fatty liver disease: diagnosis and stratification. Annu Rev Med. 2022;73:529\u201344.","journal-title":"Annu Rev Med"},{"issue":"9","key":"4115_CR7","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/imj.14709","volume":"50","author":"TD Huang","year":"2020","unstructured":"Huang TD, Behary J, Zekry A. Non-alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management. Intern Med J. 2020;50(9):1038\u201347.","journal-title":"Intern Med J"},{"issue":"10","key":"4115_CR8","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba R, Friedman SL, Shulman GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell. 2021;184(10):2537\u201364.","journal-title":"Cell"},{"issue":"1","key":"4115_CR9","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328\u201357.","journal-title":"Hepatology"},{"issue":"5","key":"4115_CR10","doi-asserted-by":"publisher","first-page":"4861","DOI":"10.3390\/ijms24054861","volume":"24","author":"J Seifert","year":"2023","unstructured":"Seifert J, Chen Y, Sch\u00f6ning W, Mai K, Tacke F, Spranger J, K\u00f6hrle J, Wirth EK. Hepatic Energy Metabolism under the Local Control of the Thyroid Hormone System. Int J Mol Sci. 2023;24(5):4861.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"4115_CR11","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.tem.2022.08.001","volume":"33","author":"E Hatziagelaki","year":"2022","unstructured":"Hatziagelaki E, Paschou SA, Sch\u00f6n M, Psaltopoulou T, Roden M. NAFLD and thyroid function: pathophysiological and therapeutic considerations. Trends Endocrinol Metab. 2022;33(11):755\u201368.","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"4115_CR12","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1186\/s12889-022-13637-4","volume":"22","author":"B Zhu","year":"2022","unstructured":"Zhu B, Li Y, Shi Y, Song N, Fang Y, Ding X. Long-term drinking behavior change patterns and its association with hyperuricemia in Chinese adults: evidence from China health and nutrition survey. BMC Public Health. 2022;22(1):1230.","journal-title":"BMC Public Health"},{"issue":"3","key":"4115_CR13","first-page":"195","volume":"26","author":"[Guidelines of prevention","year":"2018","unstructured":"[Guidelines of prevention. And treatment for nonalcoholic fatty liver disease: a 2018 update]. Zhonghua Gan Zang Bing Za zhi\u2009=\u2009zhonghua Ganzangbing Zazhi\u2009=\u2009Chinese. J Hepatol. 2018;26(3):195\u2013203.","journal-title":"J Hepatol"},{"key":"4115_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.plipres.2017.12.001","volume":"69","author":"CPJ Talbot","year":"2018","unstructured":"Talbot CPJ, Plat J, Ritsch A, Mensink RP. Determinants of cholesterol efflux capacity in humans. Prog Lipid Res. 2018;69:21\u201332.","journal-title":"Prog Lipid Res"},{"issue":"10","key":"4115_CR15","first-page":"2348","volume":"37","author":"CP Shao","year":"2021","unstructured":"Shao CP, Xu YQ. Correlation analysis of serum uric acid\/creatinine ratio with non-alcoholic fatty liver disease. J Clin Hepatol. 2021;37(10):2348\u201351.","journal-title":"J Clin Hepatol"},{"issue":"2","key":"4115_CR16","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3109\/00365515609049266","volume":"8","author":"CG Bergstrand","year":"1956","unstructured":"Bergstrand CG, Czar B. Demonstration of a new protein fraction in serum from the human fetus. Scand J Clin Lab Investig. 1956;8(2):174.","journal-title":"Scand J Clin Lab Investig"},{"issue":"4","key":"4115_CR17","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/S0168-8278(00)00053-2","volume":"34","author":"F Trevisani","year":"2001","unstructured":"Trevisani F, D\u2019Intino PE, Morselli-Labate AM, Mazzella G, Accogli E, Caraceni P, Domenicali M, De Notariis S, Roda E, Bernardi M. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol. 2001;34(4):570\u20135.","journal-title":"J Hepatol"},{"issue":"4","key":"4115_CR18","first-page":"991","volume":"35","author":"KR McIntire","year":"1975","unstructured":"McIntire KR, Waldmann TA, Moertel CG, Go VL. Serum alpha-fetoprotein in patients with neoplasms of the Gastrointestinal tract. Cancer Res. 1975;35(4):991\u20136.","journal-title":"Cancer Res"},{"issue":"11","key":"4115_CR19","first-page":"4855","volume":"42","author":"NJ Vogelzang","year":"1982","unstructured":"Vogelzang NJ, Lange PH, Goldman A, Vessela RH, Fraley EE, Kennedy BJ. Acute changes of alpha-fetoprotein and human chorionic gonadotropin during induction chemotherapy of germ cell tumors. Cancer Res. 1982;42(11):4855\u201361.","journal-title":"Cancer Res"},{"key":"4115_CR20","doi-asserted-by":"publisher","first-page":"1457598","DOI":"10.3389\/fendo.2024.1457598","volume":"15","author":"Y Xuan","year":"2024","unstructured":"Xuan Y, Wu D, Zhang Q, Yu Z, Yu J, Zhou D. Elevated ALT\/AST ratio as a marker for NAFLD risk and severity: insights from a cross-sectional analysis in the united States. Front Endocrinol. 2024;15:1457598.","journal-title":"Front Endocrinol"},{"issue":"5","key":"4115_CR21","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3390\/cells11050870","volume":"11","author":"TV Dam","year":"2022","unstructured":"Dam TV, Toft NI, Gr\u00f8ntved L. Cell-Type Resolved Insights into the Cis-Regulatory Genome of NAFLD. Cells. 2022;11(5):870.","journal-title":"Cells"},{"key":"4115_CR22","doi-asserted-by":"publisher","first-page":"574167","DOI":"10.3389\/fgene.2020.574167","volume":"11","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, Zeng Q, Li F, Fang H, Zhou Z, Jiang T, Yin C, Wei Q, Wang Y, Ruan J, et al. Dysregulated H3K27 acetylation is implicated in fatty liver hemorrhagic syndrome in chickens. Front Genet. 2020;11:574167.","journal-title":"Front Genet"},{"issue":"10","key":"4115_CR23","doi-asserted-by":"publisher","first-page":"E12","DOI":"10.1111\/hepr.12448","volume":"45","author":"K Kakisaka","year":"2015","unstructured":"Kakisaka K, Kataoka K, Onodera M, Suzuki A, Endo K, Tatemichi Y, Kuroda H, Ishida K, Takikawa Y. Alpha-fetoprotein: A biomarker for the recruitment of progenitor cells in the liver in patients with acute liver injury or failure. Hepatol Research: Official J Japan Soc Hepatol. 2015;45(10):E12\u201320.","journal-title":"Hepatol Research: Official J Japan Soc Hepatol"},{"issue":"3","key":"4115_CR24","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3233\/CH-141887","volume":"60","author":"A Vay\u00e1","year":"2015","unstructured":"Vay\u00e1 A, Rivera L, Hern\u00e1ndez-Mijares A, Bautista D, Sol\u00e1 E, Romagnoli M, Alis R. Laiz b.association of metabolic syndrome and its components with hyperuricemia in a mediterranean population. Clin Hemorheol Microcirc. 2015;60(3):327\u201334.","journal-title":"Clin Hemorheol Microcirc"},{"issue":"1","key":"4115_CR25","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12944-018-0747-z","volume":"17","author":"B Jiang","year":"2018","unstructured":"Jiang B, Zheng Y, Chen Y, Chen Y, Li Q, Zhu C, Wang N, Han B, Zhai H, Lin D, et al. Age and gender-specific distribution of metabolic syndrome components in East china: role of hypertriglyceridemia in the SPECT-China study. Lipids Health Dis. 2018;17(1):92.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"4115_CR26","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12902-020-00582-9","volume":"20","author":"A Vusirikala","year":"2020","unstructured":"Vusirikala A, Thomas T, Bhala N, Tahrani AA, Thomas GN, Nirantharakumar K. Impact of obesity and metabolic health status in the development of non-alcoholic fatty liver disease (NAFLD): A united Kingdom population-based cohort study using the health improvement network (THIN). BMC Endocr Disord. 2020;20(1):96.","journal-title":"BMC Endocr Disord"},{"issue":"4","key":"4115_CR27","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.2337\/db10-0916","volume":"60","author":"W Baldwin","year":"2011","unstructured":"Baldwin W, McRae S, Marek G, Wymer D, Pannu V, Baylis C, Johnson RJ. Sautin yy.hyperuricemia as a mediator of the Proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes. 2011;60(4):1258\u201369.","journal-title":"Diabetes"},{"key":"4115_CR28","doi-asserted-by":"publisher","first-page":"1470380","DOI":"10.1155\/2021\/1470380","volume":"2021","author":"N Liu","year":"2021","unstructured":"Liu N, Xu H, Sun Q, Yu X, Chen W, Wei H, Jiang J, Xu Y, Lu W. The Role of Oxidative Stress in Hyperuricemia and Xanthine Oxidoreductase (XOR) Inhibitors. Oxid Med Cell Longev. 2021;2021:1470380.","journal-title":"Oxid Med Cell Longev"},{"key":"4115_CR29","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000484283","volume":"192","author":"C King","year":"2018","unstructured":"King C, Lanaspa MA, Jensen T, Tolan DR, S\u00e1nchez-Lozada LG, Johnson RJ. Uric acid as a cause of the metabolic syndrome. Contrib Nephrol. 2018;192:88\u2013102.","journal-title":"Contrib Nephrol"},{"issue":"6","key":"4115_CR30","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","volume":"67","author":"TH Karlsen","year":"2017","unstructured":"Karlsen TH, Folseraas T, Thorburn D, Vesterhus M. Primary sclerosing cholangitis - a comprehensive review. J Hepatol. 2017;67(6):1298\u2013323.","journal-title":"J Hepatol"},{"issue":"8","key":"4115_CR31","first-page":"817","volume":"38","author":"LJ Zhao","year":"2016","unstructured":"Zhao LJ, Yang K. Associations between changes in red blood cell count and metabolic syndrome and its components. Beijing Med J. 2016;38(8):817\u201320.","journal-title":"Beijing Med J"},{"issue":"6","key":"4115_CR32","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/S1056-8727(04)00003-0","volume":"18","author":"YY Wang","year":"2004","unstructured":"Wang YY, Lin SY, Liu PH, Cheung BM, Lai WA. Association between hematological parameters and metabolic syndrome components in a Chinese population. J Diabetes Complicat. 2004;18(6):322\u20137.","journal-title":"J Diabetes Complicat"},{"issue":"5","key":"4115_CR33","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1507\/endocrj.K06-074","volume":"53","author":"K Kotani","year":"2006","unstructured":"Kotani K, Sakane N, Kurozawa Y. Increased red blood cells in patients with metabolic syndrome. Endocr J. 2006;53(5):711\u20132.","journal-title":"Endocr J"},{"issue":"3","key":"4115_CR34","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.diabres.2005.01.005","volume":"69","author":"T Mardi","year":"2005","unstructured":"Mardi T, Toker S, Melamed S, Shirom A, Zeltser D, Shapira I, Berliner S. Rogowski o.increased erythropoiesis and subclinical inflammation as part of the metabolic syndrome. Diabetes Res Clin Pract. 2005;69(3):249\u201355.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"4115_CR35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.dsx.2012.05.009","volume":"6","author":"K Nebeck","year":"2012","unstructured":"Nebeck K, Gelaye B, Lemma S, Berhane Y, Bekele T, Khali A, Haddis Y, Williams MA. Hematological parameters and metabolic syndrome: findings from an occupational cohort in Ethiopia. Diabetes Metabolic Syndrome. 2012;6(1):22\u20137.","journal-title":"Diabetes Metabolic Syndrome"},{"key":"4115_CR36","doi-asserted-by":"publisher","first-page":"3920196","DOI":"10.1155\/2020\/3920196","volume":"2020","author":"DM Tanase","year":"2020","unstructured":"Tanase DM, Gosav EM, Costea CF, Ciocoiu M, Lacatusu CM, Maranduca MA, Ouatu A, Floria M. The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD). J Diabetes Res. 2020;2020:3920196.","journal-title":"J Diabetes Res"},{"issue":"7","key":"4115_CR37","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1210\/jc.2010-0288","volume":"95","author":"F Guerrero-Romero","year":"2010","unstructured":"Guerrero-Romero F, Simental-Mend\u00eda LE, Gonz\u00e1lez-Ortiz M, Mart\u00ednez-Abundis E, Ramos-Zavala MG, Hern\u00e1ndez-Gonz\u00e1lez SO, Jacques-Camarena O, Rodr\u00edguez-Mor\u00e1n. M.The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347\u201351.","journal-title":"J Clin Endocrinol Metab"},{"issue":"19","key":"4115_CR38","first-page":"4595","volume":"36","author":"DF Cao","year":"2021","unstructured":"Cao DF, Xiong HF. Correlation between thyroid hormone, gonadal hormone, glycolipid metabolism indexes and bone mineral density in patients with perimenopausal syndrome. Maternal Child Health Care China. 2021;36(19):4595\u20138.","journal-title":"Maternal Child Health Care China"},{"key":"4115_CR39","doi-asserted-by":"publisher","first-page":"5083746","DOI":"10.1155\/2016\/5083746","volume":"2016","author":"\u015e Demir","year":"2016","unstructured":"Demir \u015e, \u00dcn\u00fcbol M, Aypak S, \u0130pek E, Akta\u015f S, Ekren GS, Y\u0131lmaz M, Tunca R. G\u00fcney E.Histopathologic Evaluation of Nonalcoholic Fatty Liver Disease in Hypothyroidism-Induced Rats. Int J Endocrinol. 2016;2016:5083746.","journal-title":"Int J Endocrinol."},{"issue":"6684","key":"4115_CR40","doi-asserted-by":"publisher","first-page":"eadi3332","DOI":"10.1126\/science.adi3332","volume":"383","author":"J Chen","year":"2024","unstructured":"Chen J, Zhou Y, Liu Z, Lu Y, Jiang Y, Cao K, Zhou N, Wang D, Zhang C, Zhou N, et al. Hepatic glycogenesis antagonizes lipogenesis by blocking S1P via UDPG. Sci (New York NY). 2024;383(6684):eadi3332.","journal-title":"Sci (New York NY)"},{"issue":"12","key":"4115_CR41","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","volume":"384","author":"PN Newsome","year":"2021","unstructured":"Newsome PN, Buchholtz K, Cusi K, Linder M, Okanoue T, Ratziu V, Sanyal AJ, Sejling AS. Harrison SA.A Placebo-Controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis. N Engl J Med. 2021;384(12):1113\u201324.","journal-title":"N Engl J Med"},{"issue":"11","key":"4115_CR42","first-page":"748","volume":"18","author":"K Ray","year":"2021","unstructured":"Ray K. Fatty pancreas associated with subsequent diabetes mellitus development. Nat Reviews Gastroenterol Hepatol. 2021;18(11):748.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"issue":"1","key":"4115_CR43","doi-asserted-by":"publisher","first-page":"2317348","DOI":"10.1080\/07853890.2024.2317348","volume":"56","author":"CL Hsu","year":"2024","unstructured":"Hsu CL, Wu PC, Wu FZ. Yu HC.LASSO-derived model for the prediction of lean-non-alcoholic fatty liver disease in examinees attending a routine health check-up. Ann Med. 2024;56(1):2317348.","journal-title":"Ann Med"},{"issue":"3","key":"4115_CR44","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1053\/j.gastro.2009.06.005","volume":"137","author":"A Kotronen","year":"2009","unstructured":"Kotronen A, Peltonen M, Hakkarainen A, Sevastianova K, Bergholm R, Johansson LM, Lundbom N, Rissanen A, Ridderstr\u00e5le M, Groop L, et al. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology. 2009;137(3):865\u201372.","journal-title":"Gastroenterology"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04115-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04115-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04115-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T23:04:46Z","timestamp":1757286286000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04115-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4115"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04115-3","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]},"assertion":[{"value":"8 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Ethics Committee of the Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region (affiliated with Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region). All procedures were conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"532"}}